共 50 条
- [43] Galenus von Pergamon Prize 2021-the Candidates Poteligeo® slows Tumor Progression in Mycosis fungoides and Sezary Syndrome ONKOLOGE, 2021, 27 (09): : 910 - 910
- [44] Galenus von Pergamon Prize 2021-the Candidates Poteligeo® slows Tumor Progression in Mycosis Fungoides and Sezary Syndrome HAUTARZT, 2021, 72 (10): : 899 - 899
- [45] Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e174 - e180
- [47] Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study JMIR RESEARCH PROTOCOLS, 2024, 13
- [48] Mycosis fungoides and Sézary syndrome - Simplifying the approach for dermatologists. Part 1: Etiopathogenesis, clinical features and evaluation INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2025, 91 (01): : 40 - 48
- [49] Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998–2016 BMC Health Services Research, 21
- [50] Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome? European Journal of Dermatology, 2017, 27 : 49 - 53